Caroline Schuerger (@clschuerger) profile picture

all things biotech and natsec 🧬. former @CSETGeorgetown, @CWRUSOM. cleveland forever. views my own

Joined February 2011
Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)Photo by Caroline Schuerger (@clschuerger)
Some of my last work from CSET is in print! Great working with @steph_batalis, @ggronvall, and Matt E. Walsh on the opportunities and challenges of the AI x Synthetic Bio convergence!
Sharing my new article in Applied Biosafety with Stephanie Batalis, Caroline Schuerger @clschuerger, and Matt E. Walsh on "Safeguarding Mail-Order DNA Synthesis in the Age of Artificial Intelligence." liebertpub.com/doi/epub/10.1…
2
11
708
Caroline Schuerger retweeted
Sharing my new article in Applied Biosafety with Stephanie Batalis, Caroline Schuerger @clschuerger, and Matt E. Walsh on "Safeguarding Mail-Order DNA Synthesis in the Age of Artificial Intelligence." liebertpub.com/doi/epub/10.1…
1
6
1
14
2,957
Caroline Schuerger retweeted
Much is misunderstood about gain-of-function research, and without taking a nuanced look at the issue, one-size-fits-all restrictions will do more harm than good, argue CSET's @steph_batalis + @clschuerger via @CFR_org's @ThinkGlobalHlth. Read more here ⬇️ thinkglobalhealth.org/articl…
5
11
994
Great thread by my coauthor and colleague @steph_batalis. Check out the rest of our report here: cset.georgetown.edu/publicat…
Replying to @steph_batalis
The main takeaway? Two things can be true at once: GOF/LOF research can be important for science and medicine while a subset can also be risky if conducted improperly. Differentiating between the two will require nuanced and careful policy.
2
8
754
Caroline Schuerger retweeted
First global survey reveals who is doing ‘gain of function’ research on pathogens and why go.nature.com/3LniesE
9
30
1
66
43,896
Thank you @maxdkozlov for covering our latest project on gain of function research!
The labs studying pathogens' new tricks: who is doing 'gain of function' work and why? A new @CSETGeorgetown report gives hard numbers on where GOF is happening and on which pathogens In @Nature w/ @AnnaPuglisi838 @ggronvall @GoodrumVirusLab @clschuerger nature.com/articles/d41586-0…
5
170
Caroline Schuerger retweeted
Proud of all the work that went into this report, and glad it’s finding its way to a wider audience! This is just the tip of the iceberg - but it’s important to know what kind of research is happening on a large scale.
The labs studying pathogens' new tricks: who is doing 'gain of function' work and why? A new @CSETGeorgetown report gives hard numbers on where GOF is happening and on which pathogens In @Nature w/ @AnnaPuglisi838 @ggronvall @GoodrumVirusLab @clschuerger nature.com/articles/d41586-0…
4
13
1,104
Caroline Schuerger retweeted
Important perspective from Hopkins' Matt E. Walsh: "large language model-based chatbots and bio-design tools influence the biosecurity landscape in vastly different ways. Their governance, therefore, should be considered and developed independently." thebulletin.org/2023/09/why-…
1
6
22
5,128
Our latest report adds additional insight into the gain-of-function discussion: we used machine learning to map and characterize approximately 7,000 scientific publications that use gain-or loss-of-function and discusses the regulatory opportunities and challenges
✨New Policy Brief✨ When it comes to regulating ‘risky’ gain of function research, one size does not fit all. Check out our new report describing the scale of this research + details on the range of methodologies, pathogens + public health applications. cset.georgetown.edu/publicat…
3
12
1,662
Caroline Schuerger retweeted
Gain-of-function research: what is it? How and why do researchers do it? What does the research landscape look like? So proud to be part of this report where we answer these questions and more using ~7,000 examples of gain- or loss-of-function research!
✨New Policy Brief✨ When it comes to regulating ‘risky’ gain of function research, one size does not fit all. Check out our new report describing the scale of this research + details on the range of methodologies, pathogens + public health applications. cset.georgetown.edu/publicat…
6
8
822
Caroline Schuerger retweeted
As we consider the future of LLMs in bio and medicine, the (very real!) discussion of risk needs to be balanced with the ways that LLMs already power health applications. Check out my newest blog post below with @clschuerger and @VikramVenkatram!⬇️
1
5
217
Caroline Schuerger retweeted
What does it mean to have a resilient biomanufacturing ecosystem for U.S. national security? Check out my latest report at @CSETGeorgetown ⬇️💉 #biomanufacturing #bioeconomy #biosecurity
2
5
325
BIG piece from the bio team!! Building off our previous work, this paper highlights vulnerabilities of vaccine manufacturing in the U.S.
9
369
It's finally starting to feel like springtime here in Cleveland, so it's time to play my favorite game- is it allergies, a cold, or covid? (it's definitely allergies)
1
5
240